Global Precision Medicine Market Analysis 2019

The Global Precision Medicine market is expected to reach $144.4 billion by 2026 growing at a CAGR of 14.5% from 2018 to 2026. Precision medication (PM) is a type of medication that uses information about a person’s genes, proteins, way of life, and environment to forestall, diagnose, and treat diseases. This methodology enables analysts and doctors to predict more accurately the treatment and prevention methods for a selected disease that can work for specific people. Some of the factors such as increasing the acceptance rate of gene therapies in developed economies and growing advancements in cancer biology are fuelling market growth. However, high cost of the development and increasing price of genetic testing, is restraining the market growth. Based on the technology, companion diagnostics segment has witnessed significant growth. Companion diagnostics help healthcare experts to assess the advantages and side-effects or risk of therapeutic products on a patient. The key vendors mentioned are Teva Pharmaceutical Industries Ltd, Tepnel Pharma Services, Quest Diagnostics Incorporated, Qiagen NV, Pfizer Inc., Novartis AG, Nanostring Technologies, Medtronic, Laboratory Corporation of America Holdings, Intomics, Hoffmann-La Roche, Ferrer inCode, Eagle Genomics Ltd, and Biocrates Life Sciences AG. Products Covered: • Services • Instruments • Consumables Technologies Covered: • Targeted Therapeutics • Molecular Diagnostics • Gene Sequencing • Drug Discovery • Companion Diagnostics • Bioinformatics • Big Data Analytics • Pharmacogenomics (PGX) • Other Technologies Therapeutics Covered: • Genetic Tests • Direct to Consumer Tests • Immunology • Gastroenterology • Neurology/Physiatry • Infectious Diseases • Central Nervous System (CNS) • Cardiovascular Disease (CVD) • Cancer/Oncology • Skin Diseases • Respiratory Diseases • Renal Disease • Pulmonary Disease • Ophthalmology • Metabolic Disease • Hematology End Users Covered: • Pharmaceutical Companies • Medical Devices • Hospitals • Home Care • Diagnostic Companies • Biotechnology Companies • Healthcare-IT/Big Data firms • Clinical Laboratories Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2016 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analyzed during the forecast period

1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Precision Medicine Market, By Product
5.1 Introduction
5.2 Services
5.3 Instruments
5.4 Consumables

6 Global Precision Medicine Market, By Technology
6.1 Introduction
6.2 Targeted Therapeutics
6.3 Molecular Diagnostics
6.4 Gene Sequencing
6.5 Drug Discovery
6.6 Companion Diagnostics
6.7 Bioinformatics
6.8 Big Data Analytics
6.9 Pharmacogenomics (PGX)
6.10 Other Technologies

7 Global Precision Medicine Market, By Therapeutics
7.1 Introduction
7.2 Genetic Tests
7.3 Direct to Consumer Tests
7.4 Immunology
7.5 Gastroenterology
7.6 Neurology/Physiatry
7.7 Infectious Diseases
7.8 Central Nervous System (CNS)
7.9 Cardiovascular Disease (CVD)
7.10 Cancer/Oncology
7.11 Skin Diseases
7.12 Respiratory Diseases
7.13 Renal Disease
7.14 Pulmonary Disease
7.15 Ophthalmology
7.16 Metabolic Disease
7.17 Hematology

8 Global Precision Medicine Market, By End user
8.1 Introduction
8.2 Pharmaceutical Companies
8.3 Medical Devices
8.4 Hospitals
8.5 Home Care
8.6 Diagnostic Companies
8.7 Biotechnology Companies
8.8 Healthcare-IT/Big Data firms
8.9 Clinical Laboratories

9 Global Precision Medicine Market, By Geography
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia Pacific
9.5 South America
9.6 Middle East & Africa

10 Strategic Benchmarking

11 Vendors Landscape
11.1 Teva Pharmaceutical Industries Ltd
11.2 Tepnel Pharma Services
11.3 Quest Diagnostics Incorporated
11.4 Qiagen NV
11.5 Pfizer Inc.
11.6 Novartis AG
11.7 Nanostring Technologies
11.8 Medtronic
11.9 Laboratory Corporation of America Holdings
11.10 Intomics
11.11 Hoffmann-La Roche
11.12 Ferrer inCode
11.13 Eagle Genomics Ltd
11.14 Biocrates Life Sciences AG

List of Data Tables
Table 1 Global Precision Medicine Market Outlook, By Region (2017-2026) ($MN)
Table 2 Global Precision Medicine Market Outlook, By Product (2017-2026) ($MN)
Table 3 Global Precision Medicine Market Outlook, By Services (2017-2026) ($MN)
Table 4 Global Precision Medicine Market Outlook, By Instruments (2017-2026) ($MN)
Table 5 Global Precision Medicine Market Outlook, By Consumables (2017-2026) ($MN)
Table 6 Global Precision Medicine Market Outlook, By Technology (2017-2026) ($MN)
Table 7 Global Precision Medicine Market Outlook, By Targeted Therapeutics (2017-2026) ($MN)
Table 8 Global Precision Medicine Market Outlook, By Molecular Diagnostics (2017-2026) ($MN)
Table 9 Global Precision Medicine Market Outlook, By Gene Sequencing (2017-2026) ($MN)
Table 10 Global Precision Medicine Market Outlook, By Drug Discovery (2017-2026) ($MN)
Table 11 Global Precision Medicine Market Outlook, By Companion Diagnostics (2017-2026) ($MN)
Table 12 Global Precision Medicine Market Outlook, By Bioinformatics (2017-2026) ($MN)
Table 13 Global Precision Medicine Market Outlook, By Big Data Analytics (2017-2026) ($MN)
Table 14 Global Precision Medicine Market Outlook, By Pharmacogenomics (PGX) (2017-2026) ($MN)
Table 15 Global Precision Medicine Market Outlook, By Other Technologies (2017-2026) ($MN)
Table 16 Global Precision Medicine Market Outlook, By Therapeutics (2017-2026) ($MN)
Table 17 Global Precision Medicine Market Outlook, By Genetic Tests (2017-2026) ($MN)
Table 18 Global Precision Medicine Market Outlook, By Direct to Consumer Tests (2017-2026) ($MN)
Table 19 Global Precision Medicine Market Outlook, By Immunology (2017-2026) ($MN)
Table 20 Global Precision Medicine Market Outlook, By Gastroenterology (2017-2026) ($MN)
Table 21 Global Precision Medicine Market Outlook, By Neurology/Physiatry (2017-2026) ($MN)
Table 22 Global Precision Medicine Market Outlook, By Infectious Diseases (2017-2026) ($MN)
Table 23 Global Precision Medicine Market Outlook, By Central Nervous System (CNS) (2017-2026) ($MN)
Table 24 Global Precision Medicine Market Outlook, By Cardiovascular Disease (CVD) (2017-2026) ($MN)
Table 25 Global Precision Medicine Market Outlook, By Cancer/Oncology (2017-2026) ($MN)
Table 26 Global Precision Medicine Market Outlook, By Skin Diseases (2017-2026) ($MN)
Table 27 Global Precision Medicine Market Outlook, By Respiratory Diseases (2017-2026) ($MN)
Table 28 Global Precision Medicine Market Outlook, By Renal Disease (2017-2026) ($MN)
Table 29 Global Precision Medicine Market Outlook, By Pulmonary Disease (2017-2026) ($MN)
Table 30 Global Precision Medicine Market Outlook, By Ophthalmology (2017-2026) ($MN)
Table 31 Global Precision Medicine Market Outlook, By Metabolic Disease (2017-2026) ($MN)
Table 32 Global Precision Medicine Market Outlook, By Hematology (2017-2026) ($MN)
Table 33 Global Precision Medicine Market Outlook, By End user (2017-2026) ($MN)
Table 34 Global Precision Medicine Market Outlook, By Pharmaceutical Companies (2017-2026) ($MN)
Table 35 Global Precision Medicine Market Outlook, By Medical Devices (2017-2026) ($MN)
Table 36 Global Precision Medicine Market Outlook, By Hospitals (2017-2026) ($MN)
Table 37 Global Precision Medicine Market Outlook, By Home Care (2017-2026) ($MN)
Table 38 Global Precision Medicine Market Outlook, By Diagnostic Companies (2017-2026) ($MN)
Table 39 Global Precision Medicine Market Outlook, By Biotechnology Companies (2017-2026) ($MN)
Table 40 Global Precision Medicine Market Outlook, By Healthcare-IT/Big Data firms (2017-2026) ($MN)
Table 41 Global Precision Medicine Market Outlook, By Clinical Laboratories (2017-2026) ($MN)
Table 42 North America Precision Medicine Market Outlook, By Product (2017-2026) ($MN)
Table 43 North America Precision Medicine Market Outlook, By Technology (2017-2026) ($MN)
Table 44 North America Precision Medicine Market Outlook, By Therapeutics (2017-2026) ($MN)
Table 45 North America Precision Medicine Market Outlook, By End user (2017-2026) ($MN)
Table 46 Europe Precision Medicine Market Outlook, By Product (2017-2026) ($MN)
Table 47 Europe Precision Medicine Market Outlook, By Technology (2017-2026) ($MN)
Table 48 Europe Precision Medicine Market Outlook, By Therapeutics (2017-2026) ($MN)
Table 49 Europe Precision Medicine Market Outlook, By End user (2017-2026) ($MN)
Table 50 Asia Pacific Precision Medicine Market Outlook, By Product (2017-2026) ($MN)
Table 51 Asia Pacific Precision Medicine Market Outlook, By Technology (2017-2026) ($MN)
Table 52 Asia Pacific Precision Medicine Market Outlook, By Therapeutics (2017-2026) ($MN)
Table 53 Asia Pacific Precision Medicine Market Outlook, By End user (2017-2026) ($MN)
Table 54 South America Precision Medicine Market Outlook, By Product (2017-2026) ($MN)
Table 55 South America Precision Medicine Market Outlook, By Technology (2017-2026) ($MN)
Table 56 South America Precision Medicine Market Outlook, By Therapeutics (2017-2026) ($MN)
Table 57 South America Precision Medicine Market Outlook, By End user (2017-2026) ($MN)
Table 58 Middle East & Africa Precision Medicine Market Outlook, By Product (2017-2026) ($MN)
Table 59 Middle East & Africa Precision Medicine Market Outlook, By Technology (2017-2026) ($MN)
Table 60 Middle East & Africa Precision Medicine Market Outlook, By Therapeutics (2017-2026) ($MN)
Table 61 Middle East & Africa Precision Medicine Market Outlook, By End user (2017-2026) ($MN)